SKIN CANCER NEWS
Be sure to check back frequently for top stories in skin cancer.
We are so excited to report the adoption of the landmark resolution on Skin Diseases at the 78th World Health Assembly. Your support has been invaluable in elevating the commitment to skin health worldwide.
Read the press release from Global Skin, of which we are a member organization:
New Opportunity for Advocacy!
Support the WHA 2025 Resolution on Skin Diseases!
Skin diseases affect over 4.69 billion people globally, making them one of the top 10 causes of disability. From eczema and psoriasis to rare genetic conditions, skin diseases have devastating impacts on individuals’ health, mental well-being, and livelihoods.
The World Health Assembly (WHA) will meet in May 2025 to adopt a groundbreaking resolution to prioritize skin health as a global health issue. This resolution proposes to:
- Establish a WHO Global Action Plan for Skin Diseases.
- Invest in training healthcare providers to diagnose and manage skin diseases effectively.
- Strengthen diagnostic capacity and surveillance for skin diseases.
- Promote multidisciplinary skin diseases research on new diagnostics and affordable treatments and ensure their equitable access.
- Advance research into social and economic impacts of skin diseases.
- Support integrated and holistic action on skin diseases to support patients’ needs including their mental well-being.
- Strengthen healthcare systems and improve health equity.
Join us in advocating for this crucial resolution.
- Share your support on social media using #SkinDiseasesResolution.
- Contact your Minister of Health and urge them to endorse this resolution.
- Learn more about the WHA Resolution for Skin Diseases by visiting https://globalskin.org/WHAResolution
Together, we can build a future where no one is left behind due to skin diseases.
August 18, 2024
Propensity to severe immune-related adverse events with immunotherapy: is there a genetic connection ?
While immunotherapy shows remarkable results in treating skin cancer, the burden of immune-related adverse events (irAEs) is a factor to weigh when considering the use of these regimens, particularly in the adjuvant and neoadjuvant settings. Why do some patients experience severe irAEs with immunotherapy? In a recent paper, researchers at NYU Langone identified a gene signature ( ie, enrichment in a gene called spleen tyrosine kinase) in immune cells at baseline in patients who experienced severe irAEs after receiving ipilimumab /nivolumab in the post-surgical setting. Efforts like this to find biomarkers to support therapeutic decision making regarding immunotherapy are critical to optimize outcomes.
June 5, 2024
Personalized mRNA vaccine delays melanoma relapse for three years
June 1, 2024
Lawrence: Medications might increase your risk of skin cancer
May 31, 2024
Keratinocyte Cancers most commonly located on the head and neck, US study finds
May 28, 2024
Skin Cancer risk higher in women with BRCA1 or BRCA2 gene mutations
May 24, 2024
Applying the power of knowledge to drive positive change in oncology care
May 24, 2024
Research led by Cleveland Clinic doctor finds stronger genetic risks for melanoma
May 23, 2024
Here comes the sun! What’s your skin strategy?
May 22, 2024
Understanding melanoma with a surgical oncologist
May 20, 2024
NCCN Clinical Practice Guidelines in Oncology: 2024 updates
May 17, 2024
Telemedicine allows for first-of-its-kind trial administering subcutaneous immunotherapy at home
May 15, 2024
Skin cancer awareness month: sun safety and tackling diagnosis
May 13, 2024
Protecting your skin: Facts and prevention tips for skin cancer
May 13, 2024
Patients with non-melanoma skin cancer prefer RSCT over surgery
May 10, 2024
Exciting advances in melanoma treatment
May 9, 2024
Sunblock is obnoxious (but the alternative, skin cancer, is terrifying)
May 9, 2024
Dr Hauschild on ongoing research with adjuvant immunotherapy in CSCC
May 3, 2024
Exploration into super-giant basal cell carcinoma calls for future research
May 2, 2024
Terrifying time-lapse video reveals how a tiny dark blotch can morph into stage 4 skin cancer
April 30, 2024
In the early steps of cancer formation, timing matters
April 30, 2024
When your pimple might be cancer — and how to recognize the signs
April 30, 2024
Fact vs. Fiction: debunking common misconceptions about skin cancer, sun safety
April 22, 2024
Dr Patel on the evolving use of neoadjuvant PD-1 inhibitors in CSCC
April 19, 2024
UK scientists discover two genes offering potential drug targets against skin cancer
April 18, 2024
Advanced Basal Cell Carcinoma responds to combination drug-radiation treatment
April 16, 2024
Illuminating a potential culprit in melanoma treatment resistance
April 15, 2024
Dr Michael Farwell on FDG PET/CT imaging to predict immunotherapy response in advanced melanoma
April 9, 2024
Dual checkpoint inhibition leads to higher response rates vs Anti-PD1 therapy in high-risk resectable melanoma
April 13, 2024
NCCN 2024 Annual Conference focuses on practical applications for improving cancer care
April 12, 2024
Melanomas resist drugs by ‘breaking’ genes
April 11, 2024
Global phase 3 trial investigates mRNA vaccine for melanoma treatment
April 11, 2024
When does the PD-1 inhibitor come before the Hedgehog inhibitor for neoadjuvant BCC/CSCC?
April 10, 2024
Nivolumab plus Talazoparib does not induce responses in heavily pretreated melanoma
April 9, 2024
AI-based smartphone app proves reliable in diagnosis of melanoma
March 28, 2024
Risk for second primary melanoma increases after primary melanoma diagnosis as men age
March 27, 2024
Enhanced melanoma vaccine offers improved survival for men
March 26, 2024
Castle Biosciences shares melanoma test study data at SSO 2024
March 26, 2024
Radiation therapy associated with elevated skin cancer risk in patients with breast cancer
March 25, 2024
Skin cancer: the most common cancer in America
March 19, 2024
Adjuvant Pembrolizumab in resected stage IIB or IIC melanoma
March 11, 2024
William Shatner Discusses Stage 4 Melanoma Diagnosis, Treatment | AAD 2024
March 12, 2024
Age-related changes in skin may contribute to melanoma metastases
March 12, 2024
Serving those who serve our communities: melanoma in veterans and firefighters
March 11, 2024
Should we fear the sun … or sun protection?
March 8, 2024
More research needed to address discordance in skin cancer treatment guidelines
March 7, 2024
For childhood cancer survivors, inherited genetic factors influence risk of cancers later in life
March 5, 2024
First cancer TIL therapy gets FDA approval for advanced melanoma
March 4, 2024
Cannabis may help treat melanoma skin cancer, new study suggests
March 4, 2024
Cancer is no longer a death sentence, but treatments still have a long way to go
March 3, 2024
More people are diagnosed with skin cancer each year in the U.S. than all other cancers
February 27, 2024
Experience shapes use of dual immunotherapy in advanced melanoma
February 24, 2024
Spot-checking for life: the crucial practice of skin self-examinations
February 23, 2024
Preventing cancer should not mean sacrificing quality of life
February 22, 2024
7 lifestyle tips to reduce your cancer risk
February 20, 2024
Skin cancer symptoms, causes and how to avoid getting it
February 18, 2024
AI-powered detection system for skin cancers receives FDA approval
February 16, 2024
FDA approves first cellular therapy to treat patients with unresectable or metastatic melanoma
February 15, 2024
Experts give an overview of the latest melanoma therapies
February 14, 2024
Lived experiences and fear of cancer recurrence among survivors of localized cutaneous melanoma
February 14, 2024
Risks of melanoma, other skin cancers are higher in patients treated with biologics for psoriasis
February 13, 2024
MIA calculator for predicting recurrence-free and overall survival in Stage II Melanoma
February 6, 2024
Smoking tied to increased mortality from early-stage melanoma
January 29, 2024
FDG PET/CT Imaging performed after 1 week of immunotherapy may predict treatment response in patients with advanced melanoma
January 25, 2024
Tackling the challenges of oncology workforce shortages, increased patient demand, and rising costs of care
January 23, 2024
Data from ESMO 2023 further define treatment paradigm in advanced melanoma
January 23, 2024
Natural hair color identified as potential skin cancer risk factor
January 22, 2024
After Sarah Ferguson’s diagnosis, Philadelphia doctor says breast cancer and melanoma could be linked
January 21, 2024
What is malignant melanoma?
January 18, 2024
Superficial X-Ray a well-tolerated, non-surgical option for basal and squamous cell carcinomas
January 17, 2024
Immunotherapy, academic centers may decrease mortality in metastatic cancer
January 17, 2024
Coming soon: the first mRNA vaccine for melanoma?
January 17, 2024
US FDA clears DermaSensor’s AI-powered skin cancer detecting device
January 10, 2024
City of Hope research reveals an immune cell that can attack cancer
January 9, 2024
What does melanoma look like, and where can it be found on the body?
January 9, 2024
Skin cancer’s impact on American Indian/Alaska Native Communities deserves more consideration
January 8, 2024
Cancer detection rates dropped due to COVID-19 disruptions, study finds
January 5, 2024
Using AI as an oncology nurse
January 5, 2024
Artificial Intelligence getting better at detecting skin cancer
January 5, 2024
Novel, nonsurgical BCC treatment shown safe and effective
January 5, 2024
Lifileucel demonstrates long-term efficacy and survival benefit in advanced, pretreated melanoma
January 5, 2024
A combined opposite targeting of p110δ PI3K and RhoA abrogates skin cancer
January 3, 2024
Is itchy skin a sign of cancer?
December 29, 2023
MHRA approves Bristol Myers Squibb’s Opdualag for advanced melanoma treatment
December 26, 2023
This benign skin condition may be a sign of something much worse – here’s what you should know
December 20, 2023
What one derm wants you to know about advanced non-melanoma skin cancer—no matter your skin color
December 14, 2023
Moderna, Merck vaccine with Keytruda cuts risk of deadly skin cancer returning in half, data says
December 13, 2023
Immunotherapy and radiation therapy in cSCC and BCC
December 12, 2023
Updated guidelines for systemic therapy for melanoma addresses new research
December 7, 2023
The increased risk of skin cancer in patients with autoimmune and inflammatory conditions
December 5, 2023
Study: older patients with actinic keratoses at increased risk of skin cancer
December 4, 2023
Skin cancer detection with AI: how intelligent is it?
December 2, 2023
Tumor, stress and anxiety promote cancer growth and make treatments less effective: the study
November 29, 2023
Moffitt researchers identify cell signaling pathway controlling melanoma cell metastasis to the brain
November 28, 2023
You may be increasing your skin cancer risk without knowing it
November 27, 2023
Study indicates potential of Pembrolizumab in advanced melanoma
November 10, 2023
Managing expectations of treatment for infiltrative basal cell carcinoma
November 7, 2023
Dr Ronai on key advances in melanoma treatment approaches
November 8, 2023
Working under the sun causes 1 in 3 deaths from non-melanoma skin cancer, say WHO and ILO
November 3, 2023
Young men at higher risk for mortality from invasive cutaneous melanoma than young women
November 3, 2023
AI revolutionizes skin cancer detection with high accuracy
October 31, 2023
Patients with newly diagnosed NSCLC or Melanoma may receive limited documentation of treatment cost discussions
October 30, 2023
Is it just a stubborn rash, or is it a little-known sign of skin cancer?
October 27, 2023
Novel therapies have significantly improved melanoma outcomes, with more exciting options to come
October 11, 2023
Novel drug, NFX-179, inhibits MEK activity, prevents cutaneous squamous cell carcinoma development
October 10, 2023
Why non-melanoma skin cancer is now more deadly than melanoma worldwide
October 6, 2023
Hands-on BCC approach
October 5, 2023
Expert perspectives on BOLT clinical trial data
October 4, 2023
Actinic keratosis – a common skin condition that can lead to skin cancer
October 3, 2023
PDS Biotech announces interim 24-month survival rate of 74% in immune checkpoint inhibitor naïve head and neck cancer patients Treated with PDS0101 in combination with KEYTRUDA® (pembrolizumab)
September 30, 2023
Noninvasive technique for the screening and diagnosis of oral squamous cell carcinoma
September 28, 2023
Skin cancer in children: How to tell if it’s more than just a mole
September 18, 2023
AACR issues annual cancer progress report highlights scientific advances against cancer and the challenges and opportunities ahead
September 17, 2023
New cancer drugs are changing the odds. the latest on treatments.
September 16, 2023
Managing stress after cancer
September 15, 2023
Frontline Forum part 2: improving basal cell carcinoma management
September 13, 2023
Use of high-frequency ultrasound can improve diagnostic accuracy and determinacy of subcutaneous lesions
September 13, 2023
Frontline forum part 1: improving basal cell carcinoma management
September 12, 2023
COVID-19 pandemic may have led to a reduction in skin cancer screening access
September 4, 2023
What is Merkel cell skin cancer? The signs and symptoms of rare condition that killed Jimmy Buffett
September 2, 2023
Jimmy Buffett’s cause of death revealed as Merkel Cell Skin Cancer
August 30, 2023
Patient perception of skin cancer reduction by nicotinamide correlates with use
August 30, 2023
Nonsurgical treatment for nonmelanoma skin cancer exhibits 99% cure rate
August 30, 2023
Skin cancer: causes, types, prevention and treatment
August 27, 2023
How sunglasses can protect your eyes
August 25, 2023
Merck, Eisai discontinue Phase III trial of Keytruda, Lenvima combo therapy
August 22, 2023
Guidelines for surgical treatment of early-stage vulvar squamous cell carcinomas
August 21, 2023
Recognizing and managing pediatric skin cancer with early detection and education
August 18, 2023
How pharmacists can help protect patients’ skin from sunburn, skin cancer
August 10, 2023
Types of skin cancer and their treatments
August 9, 2023
Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma: appropriate patient selection and perspectives
August 8, 2023
Yes, you should wear sunscreen every day
August 2, 2023
Considerations for Hedgehog vs immunotherapy in patients with basal cell carcinoma
July 31, 2023
Cosibelimab yields enduring responses in metastatic/advanced cutaneous SCC
July 29, 2023
Roundtable roundup: Skin Cancer
July 28, 2023
Skin cancer screenings and melanoma outcomes among racial and ethnic minority patients
July 24, 2023
Using a patient’s immune system to treat skin cancer
July 24, 2023
Management dilemma in a large fungating Squamous Cell Carcinoma over a Marjolin’s Ulcer on the chest wall coexisting with severe post-burn contracture of the neck
July 21, 2023
Melanoma and skin cancer in South Africa
July 21, 2023
VERIFY fact sheet: what to know about skin cancer and skin tone
July 20, 2023
Organ recipients with cutaneous squamous cell carcinoma show higher rates of metastasis death compared to non-recipients
July 19, 2023
Skin cancer: signs to look out for such as patches and moles as Loose Women star Coleen Nolan reveals diagnosis
July 18, 2023
Basal cell carcinoma of the hand presenting with severe sepsis
July 12, 2023
ASP-1929 plus pembrolizumab produces responses, proves safe in recurrent or metastatic HNSCC
July 6, 2023
Facial squamous cell carcinomas successfully treated with topical solution and laser therapy
July 5, 2023
UV awareness is crucial to reducing the burden of skin cancer
July 3, 2023
Here’s what you should do immediately after you get a sunburn
June 23, 2023
Study supports new NCCN classification for cutaneous squamous cell carcinoma
June 21, 2023
Choosing the right sunscreen: How to protect yourself from skin cancer
June 21, 2023
Poorer prognostic characteristics seen in Squamous Cell Carcinomas in recipients of organ transplants
June 17, 2023
After decades of limited treatment options, new treatments are showing promise for non-Melanoma skin cancer
June 16, 2023
Topical N-Phosphonacetyl-L-Aspartate efficacy in nonmelanoma skin cancers
June 12, 2023
2 sneaky warning signs of Skin Cancer doctors say women over 40 shouldn’t ignore
June 7, 2023
Correlation of ultraviolet radiation levels with the incidence of cutaneous squamous cell and merkel cell carcinomas in non-sunbelt locales in the United States: 2010-2017
June 5, 2023
Moderna and Merck cancer vaccine used with Keytruda reduces risk of deadly skin cancer spreading
June 5, 2023
MATISSE phase 2 trial shows ‘impressive’ results with neoadjuvant IO in advanced cutaneous squamous cell carcinoma, but prospective studies needed
May 31, 2023
Diffusing Alpha-Emitter Radiation Therapy for recurrent or unresectable skin cancers
May 30, 2023
Skin cancer: how to spot it and what happens next
May 26, 2023
A Skin Cancer Diary: From Mohs Surgery and Radiation to Immunotherapy
May 25, 2023
Nonmelanoma skin cancer risks are higher when using methotrexate for psoriasis: study
May 23, 2023
Patients with vitiligo have reduced incidences of skin cancer
May 20, 2023
Addressing skin cancer: from screening to treatment
May 17, 2023
Optimizing CSCC management requires a multifaceted approach to care
May 5, 2023
How to check if you have skin cancer: Symptoms and signs to look out for
May 5, 2023
Cemiplimab granted full approval for metastatic basal cell carcinoma
April 27, 2023
Basal and squamous cell carcinomas: what’s the difference?
April 22, 2023
Oncology pharmacists are crucial in skin cancer management
April 21, 2023
Head, neck region found to be most common location for squamous cell carcinoma
April 18, 2023
AAD Statement on USPSTF recommendation on skin cancer screening
April 15, 2023
Skin cancer isn’t just for skin: Six surprising places the disease can emerge
April 12, 2023
First dosing of patient in Phase 2 study evaluating VP-315 for BCC
April 10, 2023
Millennials, Gen Xers at increased risk of nonmelanoma skin cancer
April 7, 2023
Merck, Eisai to discontinue late-stage study for skin cancer
April 6, 2023
Zynyz approved for metastatic or recurrent locally advanced Merkel Cell Carcinoma
March 28, 2023
AAD: risk for skin cancer higher for adults with atopic dermatitis
March 23, 2023
FDA grants accelerated approval to retifanlimab-dlwr for metastatic or recurrent locally advanced Merkel Cell Carcinoma
March 23, 2023
Research autopsies reveal how incurable skin cancer resists treatment
March 19, 2023
Higher cancer rates in military pilots, ground crews: Study finds
March 18, 2023
Immunosuppression linked to increased mortality risk in Squamous Cell Carcinoma
March 14, 2023
FDA issues safety communication on reports of squamous cell carcinoma in the capsule around breast implants
March 13, 2023
Basal Cell Carcinoma: a review
March 9, 2023
Nicotinamide for chemoprevention of skin cancer in solid organ transplant recipients
March 2, 2023
FDA considers approval of cosibelimab for advanced cutaneous squamous cell carcinoma
February 23, 2023
Moderna’s combination skin cancer therapy receives FDA’s breakthrough tag
February 22, 2023
Methotrexate may be linked to higher risk of skin cancers
February 21, 2023
The human microbiota and skin cancer
February 20, 2023
Global trends and research progress of photodynamic therapy in skin cancer: a bibliometric analysis and literature review
February 10, 2023
Expert talks types of skin cancer surgery, and what to expect with each
February 10, 2023
Roundtable discussion: examining the challenges of hedgehog pathway inhibitors and immunotherapy in Basal Cell Carcinoma
February 7, 2023
Immunosuppressive drug methotrexate linked to increased risk of three types of skin cancer
February 3, 2023
Pregnancy-related skin changes or skin cancer? How to tell the difference
February 1, 2023
Sirnaomics Accelerates Clinical Development of STP705 for the Treatment of Non-Melanoma Skin Cancers
January 26, 2023
Artificial human skin paves the way to new skin cancer therapy
January 26, 2023
Hedgehog inhibitor therapy’s use in Advanced Basal Cell Carcinoma – does it work?
January 25, 2023
Review explores advanced Basal Cell Carcinoma mechanisms and targeted therapies
January 15, 2023
What’s new in skin cancer
January 11, 2023
Simple laser treatments may prevent nonmelanoma skin cancer
January 4, 2023
FDA approval sought for Cosibelimab in advanced cutaneous squamous cell carcinoma
January 4, 2023
Harnessing the immune system to fight Basal Cell Carcinoma: what are the risks?
December 21, 2022
Novel, nonsurgical BCC treatment shown safe and effective
December 19, 2022
MediWound announces positive Results in U.S. Phase I/II Study of MW005 for the treatment of basal cell carcinoma
December 14, 2022
Sirnaomics announces positive interim data from phase IIb clinical trial of STP705 in adults with cutaneous squamous cell carcinoma in situ
December 10, 2022
Real-world data demonstrate strength, durability of checkpoint inhibitor use in cSCC
December 6, 2022
Solid organ transplant patients at higher risk for skin cancer and require coordinated care
November 30, 2022
Ras drives malignancy through stem cell crosstalk with the microenvironment
November 29, 2022
Roundtable discussion: Savvides analyzes role of hedgehog inhibitors and Immunotherapy in BCC
November 20, 2022
Cornulin as a potential novel biomarker for cutaneous squamous cell carcinoma
November 18, 2022
Lack of consensus regarding follow-up after keratinocyte carcinoma treatment
November 15, 2022
Multidisciplinary discussions shape systemic and surgical skin cancer treatment
October 31, 2022
What is neoadjuvant immunotherapy for skin cancer?
October 25, 2022
US Preventive Services Task Force: Evidence still lacking for routine skin cancer screening
October 24, 2022
Phase II clinical trial generates promising results for immunotherapy drug nivolumab in patients with advanced skin cancer
October 23, 2022
Treating skin cancers in the immunotherapy era
October 22, 2022
Neurofibromatosis Type 1 linked to greater skin cancer risk
October 17, 2022
Skin and brain cancers: new discovery may help improve treatment
October 14, 2022
Moderna teams up with Merck for personalized vaccine against skin cancer
October 7, 2022
Certain patients who have BCC may benefit from electrochemotherapy
October 6, 2022
New directions in the treatment of basal cell carcinoma
September 24, 2022
Dermoscopy holds limited potential to differentiate BCC from benign tumors
September 23, 2022
Cutaneous Basal Cell Carcinoma in situ: a case series
September 12, 2022
Neoadjuvant Cemiplimab for stage II to IV cutaneous squamous-cell carcinoma
September 9, 2022
FDA issues statement on new cases of rare breast implant-related cancers
September 7, 2022
Vitamin D levels affect overall survival for skin cancer patients
September 5, 2022
CR achieved in all patients with cutaneous BCC given high-dose STP705
August 29, 2022
Who’s at increased risk for skin cancer?
August 23, 2022
New resource from Patient Empowerment Network: Advanced Non-melanoma Skin Cancer Patient Toolkit.
August 17, 2022
Skin cancer knowledge suboptimal among patients
August 10, 2022
PASS Coalition applauds National Academy of Sciences study on sunscreen impacts and its support of sunscreen as a skin cancer prevention tool
August 8, 2022
Immuno-Genomic features predict treatment response in esophageal carcinoma
August 8, 2022
Skin cancer cells harness nerve cell gene to drill through and invade new tissues
August 4, 2022
Society for Immunotherapy of Cancer (SITC) publishes clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer
August 3, 2022
Skin cancer is a risk for all skin tones, but may be overlooked in people with dark skin
July 25, 2022
Fact check-evidence shows sun exposure, not diet, causes skin cancers
July 23, 2022
Why your sunscreen isn’t working
July 22, 2022
Bristol Myers Squibb receives positive CHMP opinion recommending approval for LAG-3-Blocking Antibody Combination Opdualag (nivolumab and relatlimab) for treatment of patients with unresectable or metastatic melanoma
July 20, 2022
Phase I/II study of topical biologic shows positive results for the treatment of basal cell carcinoma
July 18, 2022
Healthier together: UV safety and avoiding skin cancer
July 13, 2022
Understand how to protect yourself from UV ray exposure and reduce sunburn
July 12, 2022
What you need to know about skin cancer on the scalp
July 12, 2022
How to enjoy the summer sun while preventing skin cancer: tips from a dermatologist
July 7, 2022
High-risk Mohs surgery outcomes superior to historical data for cSCC, study shows
June 30, 2022
Determining whether adding RP1 to Cemiplimab helps CSCC patients
June 30, 2022
If this sounds like you, you are risk of skin cancer
June 26, 2022
All of the fun, none of the melanoma
June 25, 2022
Experimental treatment increases skin cancer survival rate by 25%
June 22, 2022
Wear the Gown: African-Americans and skin cancer
June 22, 2022
Are you skin savvy?
June 21, 2022
Why do I get white spots on my skin from the sun?
June 20, 2022
Cancer from the sun month – June 2022
June 18, 2022
Bad habits that lead to skin cancer, says doctor
June 18, 2022
Habits secretly increasing your skin cancer risk, say oncologists
June 16, 2022
Cosibelimab continues to show promise in locally advanced cutaneous squamous cell carcinoma
June 10, 2022
Single-cell analysis of human basal cell carcinoma reveals novel regulators of tumor growth and the tumor microenvironment
May 31, 2022
Usage of immunotherapy in merkel cell carcinoma
May 19, 2022
Data from second independent multi-center study of patients with high-risk cutaneous squamous cell carcinoma confirms independent risk-stratification performance of decisionDx®-SCC
May 16, 2022
Immunotherapy offers hopeful outcomes in nonmelanoma skin cancers
May 13, 2022
Is Bowen’s Disease an early form of skin cancer?
May 5, 2022
Optimize co-management planning to combat advanced BCC – Dermatology Times
May 5, 2022
Spatial analysis of photoplethysmography in cutaneous squamous cell carcinoma
April 22, 2022
Some reassurance on neurologic effects of checkpoint inhibitors
April 21, 2022
What is octocrylene?
April 20, 2022
Modern management of aggressive non-melanoma skin cancers
April 20, 2022
Can a blood test help diagnose skin cancer?
April 19, 2022
Systemic advances shine, but multidisciplinary approaches remain at core of skin cancer treatment
April 15, 2022
Tumor-directed oncolytic immunotherapies show promise in replimune clinical update
April 15, 2022
2022: meeting the challenges of advanced BCC
April 14, 2022
Study supports reclassification of cutaneous squamous cell carcinoma
April 13, 2022
Primary Care Screening for Skin Cancer Appears to Boost Early Detection
April 13, 2022
Skin cancer and the cutaneous microbiome: thinking small may produce big results
April 12, 2022
Primary tumor location in MCC has prognostic significance
April 12, 2022
Sunscreen doesn’t protect as well as it could: Here is what is missing
April 12, 2022
Treatment Options for Squamous Cell Carcinoma
April 12, 2022
Solid organ transplant recipients are at an increased risk of developing non-melanoma skin cancers
April 8, 2022
Study identifies risk factors for skin cancer in older adults, highlights utility of screening and prevention
April 8, 2022
Here’s what skin cancer looks like, dermatologists say
April 7, 2022
Spontaneous regression rates of actinic keratosis: a systematic review and pooled analysis of randomized controlled trials
April 6, 2022
RP1/Nivolumab combo produces deep, durable responses in melanoma and other skin cancers
April 4, 2022
Combining novel PARP7 inhibitor with pembrolizumab to treat SCCL
April 2, 2022
Study supports reclassification of cutaneous squamous cell carcinoma
April 1, 2022
How an AI-powered tool could help diagnose skin cancer in veterans
March 31, 2022
Sticky nanoparticles fight skin cancer
March 30, 2022
Scientific sunburn & skin cancer (Part 2)
March 28, 2022
Panel addresses therapeutic, risk stratification considerations for advanced nonmelanoma skin cancers
March 27, 2022
Tips for diagnosing and managing MCC
March 26, 2022
Controversies in skin cancer screening: the debate rages on
March 25, 2022
Updates in the management of high-risk cutaneous squamous cell carcinoma
March 18, 2022
S-ITM a prognostic factor for outcomes of cutaneous squamous cell carcinoma
March 17, 2022
A case of metastatic basal cell carcinoma (BCC) with spinal and pulmonary metastases treated with vismodegib, sonedigib, and radiotherapy
March 16, 2022
Oncolytic virus plus Nivolumab demonstrates durable response in nonmelanoma skin cancer of the head and neck
March 15, 2022
Plasmid DNA vaccine candidate’s phase 1 study targets rare but aggressive form of skin cancer
March 15, 2022
Incidence trends and survival prediction of malignant skin cancer: a SEER-based study
March 11, 2022
New research seeks to incorporate immunotherapy into early lines of SCC treatment
March 2, 2022
Significant Biomarkers Identification Associated with Cutaneous Squamous Cell Carcinoma Progression
February 28, 2022
Discovering a potential explanation for treatment resistance in skin cancer
February 26, 2022
Patients with non-melanoma skin cancer achieved promising antitumor activity following treatment with RP1 and nivolumab.
February 23, 2022
Sirnaomics Announces Promising Interim Data from Phase II Clinical Trial of STP705, a Dual TGF-Beta-1/COX-2 Inhibitor, for Treatment of Cutaneous Basal Cell Carcinoma
February 23, 2022
Merkel cell carcinoma has a higher post-treatment recurrence rate than other skin cancers
February 22, 2022
New bifunctional antibody, BCA101, is being studied alone and in combination with pembrolizumab in patients with squamous cell skin cancer who have failed anti-PD-1 inhibitor therapy
February 22, 2022
More skin cancer reported to FDA from patients on certain oral disease-modifying therapies
February 20, 2022
Atezolizumab fails to meet PFS endpoint in advanced penile squamous cell carcinoma
February 19, 2022
Your next skin cream may come from NASA’s outer space science
February 18, 2022
Study: knowing skin cancer risk may limit unhealthy behavior
February 16, 2022
Progress in study combining PD-1 inhibitor pembrolizumab and anti-inflammatory drug vilobelimab in squamous cell skin cancer
February 15, 2022
Early studies investigate novel vaccine strategy in Merkel cell carcinoma
February 15, 2022
What it’s like to have Mohs skin-cancer surgery?
February 14, 2022
Skin cancer risk factors, health behaviors differ among Asian American groups
February 14, 2022
First patients registered into first international registry for non-melanoma skin cancer treatments
February 9, 2022
Dosing of efineptakin alfa/atezolizumab begins in study of patients with advanced skin cancer
February 9, 2022
Knowledge of high skin cancer risk might modify risky behaviors
February 7, 2022
Immunomic Therapeutics announces clinical trial of ITI-3000 for the treatment of merkel cell carcinoma
February 7, 2022
NeoImmuneTech announces first patient dosed in phase 2 study of NT-I7 (efineptakin alfa) with PD-L1 checkpoint inhibitor in high-risk skin cancers
February 4, 2022
Immunotherapy for nonmelanoma skin cancer: Facts and hopes
February 2, 2022
Trends in skin cancer incidence linked to sociological factors
February 2, 2022
Cosibelimab achieves promising responses in metastatic cutaneous squamous cell carcinoma
January 31, 2022
Management of elderly patients with advanced cutaneous squamous cell carcinoma
January 27, 2022
Worden discusses use of hedgehog pathway inhibitors in treating basal cell carcinoma
January 26, 2022
Skin cancer risk factors identified in Asian Americans
January 25, 2022
Cosibelimab elicits encouraging responses in metastatic cutaneous squamous cell carcinoma
January 25, 2022
Know the signs of skin cancer – and visit your GP if you’re worried
January 21, 2022
Former sunbed user left with bald patch after skin cancer created hole in scalp
January 18, 2022
How should people with dark skin check for skin cancer?
January 14, 2022
Current perspectives in the treatment of locally advanced basal cell carcinoma
January 14, 2022
Ultrasonography (US) is better than clinical examination for the detection of lymph node (LN) metastases in patients with squamous cell carcinoma (SCC) but is associated with higher rate of false positives
January 12, 2022
Researchers find new potential targets for skin-cancer treatment
January 12, 2022
Clinical and pathological characteristics of 755 patients with skin cancers in Hainan, China
January 11, 2022
New report assessed existing staging systems for cutaneous squamous cell carcinoma (cSCC)
January 10, 2022
Cancer symptoms: The warning sign to notice on your neck, face and ears
January 6, 2022
FDA accepts investigational new drug application for RM-1995 photoimmunotherapy treatment in advanced cutaneous or head and neck squamous cell carcinoma
January 5, 2022
Skin cancer is on the rise in Canada
January 5, 2022
Skin cancer expert Dr. Omar Ibrahimi on the treatment of skin cancer
January 4, 2022
Azathioprine may increase risk of cutaneous squamous cell carcinomas in solid organ transplant recipients
January 3, 2022
Drs In, Cohen, and Bakst discuss the use of other therapies for cutaneous squamous cell carcinoma, as well as what they believe is the future of systemic therapy for this disease
December 29, 2021
Study shows long-term risk of skin cancer and lymphoma in users of topical tacrolimus and pimecrolimus
December 22, 2021
Dermatologists warn summer alcohol consumption may increase risk of skin cancer
December 21, 2021
Researchers find new potential targets for skin cancer treatment
December 20, 2021
Metastatic basal cell carcinoma arising from a primary cutaneous carcinosarcoma
December 16, 2021
Patients with skin of color experience disparities in non-melanoma skin cancer
December 15, 2021
Rakuten Medical, Inc today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Investigational New Drug (IND) application to begin clinical studies of RM-1995 photoimmunotherapy in patients with advanced cutaneous squamous cell carcinoma or with head and neck squamous cell carcinoma
December 15, 2021
Top 5 Skin Cancer-Related Articles of 2021
December 14, 2021
Mohs micrographic surgery is more cost effective than wide local excision for T2a cutaneous squamous cell carcinomas
December 13, 2021
Radiation approaches for cutaneous squamous cell carcinoma and standard of care
December 13, 2021
OCT-guided hyperthermic treatment noninvasive option for superficial basal cell carcinoma
December 12, 2021
Azathioprine is associated with an increased incidence of cutaneous squamous cell carcinomas among solid organ transplant recipients
December 4, 2021
Population ‘underestimates’ skin cancer, says dermatologist
December 3, 2021
Value of cemiplimab in progressive metastatic cutaneous squamous cell carcinoma after kidney transplantation: a case report
November 24, 2021
OncoBeta launches international registry for non-melanoma skin cancer
November 23, 2021
Exploring the link between inflammation and skin cancer risk
November 18, 2021
Results from investigator-initiated phase II clinical study of remetinostat in patients with squamous cell carcinoma published
November 18, 2021
Verrica announces FDA acceptance of clinical trial application for skin cancer therapy
November 16, 2021
South African non-melanoma skin cancer patients now have greater access in the area of Johannesburg to innovative non-invasive treatment Rhenium-SCT®
November 13, 2021
Prompt response of advanced cutaneous squamous cell carcinoma to cemiplimab in a kidney transplant patient under everolimus treatment
November 12, 2021
Dr. Khushalani discusses the use of immunotherapy for patients with advanced skin cancer
November 3, 2021
Alpha Tau announces enrollment of first patient in combination trial of Alpha DaRT™ and pembrolizumab (Keytruda®) for the treatment of recurrent unresectable or metastatic squamous cell carcinoma of the head and neck
November 1, 2021
Organ transplant recipients (OTRs) may be at risk of developing multiple skin cancers, according to a study published in JAMA Dermatology
October 27, 2021
Alexander J. Stratigos, MD, PhD, discusses the effect cemiplimab will have on the treatment landscape of patients with advanced BCC.
October 27, 2021
What to know about Mohs surgery
October 26, 2021
Treatment with hedgehog pathway inhibitor vismodegib was well tolerated and associated with high rates of response in patients with locally advanced and metastatic basal cell carcinoma (BCC), according to study findings published in Dermatologic Therapy
October 19, 2021
How the emergence of immunotherapy has impacted practice patterns for treatment and management of merkel cell carcinoma
October 13, 2021
Overcoming resistance to immunotherapy in advanced cutaneous squamous cell carcinoma
October 6, 2021
How to recognize an infection after skin cancer removal
October 5, 2021
Study: New portable device for at-home skin cancer treatment
October 4, 2021
Dr Christine Ko on Making Tough Skin Cancer–Related Decisions for Transplant Patients
October 1, 2021
Portable photodynamic therapy device could pave the way for at-home treatment of basal cell carcinoma
September 30, 2021
Genomic Similarities in Actinic Keratosis and Cutaneous Squamous Cell Carcinoma Found
September 23, 2021
How Merkel Cell Carcinoma Is Treated
September 23, 2021
Staying safe under the sun: How melanin levels can significantly affect skin cancer risk
September 17, 2021
New research from the University of Birmingham suggests that skin cancer patients could have a better prognosis if their T cells have stronger receptor signal strength
September 15, 2021
Image-Guided Superficial Radiotherapy for BCC and SCC
September 15, 2021
Recent updates in Merkel Cell Carcinoma management
September 14, 2021
DermTech has created a pigmented lesion assay test in order to diagnose skin cancer without the need for invasive biopsies
September 13, 2021
Could Artificial Intelligence Diagnose Skin Cancer?
September 9, 2021
OncoBeta initiates international EPIC-Skin study with Rhenium-SCT® for the treatment of non-melanoma skin cancer
September 8, 2021
Image-Guided Superficial Radiotherapy Highly Effective in Treating Skin Cancers Without Surgery
September 3, 2021
Dermatology group in North Carolina offers free local skin cancer screenings in the month of September
August 29, 2021
Study finds that topical remetinostat gel is effective in treating basal cell carcinoma
August 29, 2021
Roundtable Discussion: Participants Review the Potential Toxicities of Hedgehog Inhibitors in Basal Cell Carcinomas
August 27, 2021
How to check moles for signs of skin cancer
August 25, 2021
Alton Memorial Hospital is offering free skin cancer screenings on Tuesday, September 28th
August 18, 2021
The Destination Healthy Skin RV has begun its journey to 21 cities in 2021
August 17, 2021
Childhood skin cancer and how to prevent it
August 12, 2021
Tampa clinic is 1 of 2 in the U.S. using bladeless, electron beam therapy to treat skin cancer
August 12, 2021
Positive data from the remetinostat phase II study in basal cell carcinoma published in clinical cancer research
August 12, 2021
Researchers identify skin darkening enzyme that could help prevent skin cancers
August 9, 2021
Scripps Health offers free skin cancer screenings for state lifeguards and other first responders in California
August 6, 2021
Orlando Health pioneers late stage skin cancer treatment
August 6, 2021
An open-label, phase ½ clinical trial will test safety and efficacy of rigosertib in treating recessive dystrophic epidermolysis bullosa in people with cutaneous squamous cell carcinoma
August 6, 2021
Histone deacetylation inhibitor shows promise for treating basal cell carcinoma
August 5, 2021
Skin cancer survivor shares story to raise awareness
August 1, 2021
Managing and preventing skin cancer: what you should know
July 28, 2021
‘The Sun Bus’ to offer free skin cancer screenings across Colorado in August
July 27, 2021
Cemiplimab deemed active, safe after hedgehog inhibitor therapy (HHI) in locally advanced basal cell carcinoma
July 26, 2021
MediWound begins phase ½ study of MW005 for the treatment of low-risk basal cell carcinoma
July 26, 2021
MediWound Starts Testing MW005 in Two Mid-Stage Trials in Patients With Non-Melanoma Skin Cancer
July 21, 2021
Risk factors for skin damage this summer
July 14, 2021
Ask the Expert: How Often Do I Need to Reapply Sunscreen If I’m Indoors All Day?
July 12, 2021
Experimental skin cancer vaccine developed by researchers at Morphogenesis dramatically reduces Merkel cell carcinoma tumor size in patient at Moffitt Cancer Center
July 12, 2021
FDA approves Keytruda for the treatment of patients with locally advanced cutaneous squamous cell carcinoma
July 8, 2021
Radiation Therapy in Skin Cancer
July 6, 2021
Prescribed topical treatments may minimize scarring for patients with skin cancer
June 30, 2021
Oncologist shares top tips to know to protect yourself from skin cancer
June 25, 2021
UCLA geneticists have traced gecko color to gene implicated in human skin cancers
June 22, 2021
Poll: Many ‘High-Risk’ Americans Unconcerned About Skin Cancer
June 22, 2021
Dermatologist talks about strategies to prevent skin cancer
June 21, 2021
Why you shouldn’t delay skin cancer screening
June 17, 2021
Tips on choosing and using sunscreen
June 16, 2021
Sirnaomics announces acceptance of investigational new drug application by China NMPA for Global Multicenter Phase 2b Trial of STP705 Treatment for Skin Squamous Cell Carcinoma
June 16, 2021
New targets may improve the treatment of rare skin cancer
June 14, 2021
Memphis physician shares tips on how to protect against skin cancer
June 11, 2021
Cetuximab after disease progression with immunotherapy in advanced skin cancer
June 9, 2021
Sunburns and skin cancer, what you can do to lower your risk
June 8, 2021
InflaRx doses first patient in multicenter phase II clinical trial in cutaneous squamous cell carcinoma with vilobelimab
June 8, 2021
The Mind-Skin Stress Connection and its relationship with skin cancer
June 3, 2021
Treatment options for basal cell skin cancer
June 3, 2021
Research led by scientists at the University of Manchester suggests that women may have a stronger immune response to a common form of skin cancer than men
June 3, 2021
Asan Medical center uses 3D printing to treat skin cancer
June 2, 2021
Hawai’i experts spread awareness about sun exposure safety this summer
May 27, 2021
World class skin cancer diagnostic technology to screen skin anomalies in a pain-free, non-invasive manner
May 26, 2021
If skin cancer is caught early, Mohs micrographic surgery procedure is one available treatment that can be completed in a single office visit
May 25, 2021
What you should know about skin cancer
May 19, 2021
Skin cancer risks and prevention tips
May 19, 2021
Skin Cancer, When Found and Treated Early, is Highly Curable
May 18, 2021
8 Sneaky Spots Skin Cancer Likes to Hide, According to Dermatologists
May 17, 2021
Recent News and Updates in the Field of Skin Cancer
May 12, 2021
Checkpoint Therapeutics announces completion of enrollment in the registration-enabling trial of cosibelimab in metastatic cutaneous squamous cell carcinoma
May 11, 2021
Scientists develop a hydrogel mixed with a sample of the patient’s cells to replace cartilage post basal cell carcinoma surgery
May 11, 2021
Actinic keratosis incrementally increases risk for skin cancer each year after diagnosis
May 11, 2021
Dermatologists share tips for preventing skin cancer year-round
April 25, 2021
Tips to improve high-risk skin cancer management from the American Academy of Dermatology
April 25, 2021
Sirnaomics initiates phase 2b study using STP705 for treatment of squamous cell skin cancer
April 23, 2021
Dr. Todd Schlesinger discusses treatments for advanced skin cancers
April 22, 2021
Keytruda shows promise for patients with locally advanced or recurrent/metastatic cutaneous squamous cell carcinoma
April 19, 2021
A new clinical trial for skin cancer patients will evaluate cemiplimab for squamous cell carcinoma at George Washington University
April 13, 2021
Study suggests common oral drug currently used to treat neuromuscular diseases could be used to prevent certain skin cancers caused by ultraviolet-B radiation
April 12, 2021
Prolonged intake of antihypertensive medications associated with higher rates of skin cancers in older adults
April 9, 2021
Free monthly skin cancer screenings resume at Alton Memorial Hospital in Illinois
April 8, 2021
Free skin cancer screenings to be provided by Dr. Metlis through Hannibal Regional Medical Group
April 8, 2021
FDA’s Libtayo approval offers another treatment option for patients with locally advanced basal cell carcinoma if they have not been successful with Hedgehog pathway inhibitors
March 29, 2021
Keeping an eye out for skin cancer
March 29, 2021
Ten-year follow-up of persons with sun-damaged skin associated with subsequent development of cutaneous squamous cell carcinoma
March 29, 2021
Actinic Keratosis Diagnosis Ups Cumulative Risk for Skin Cancer
March 26, 2021
What is Merkel Cell Carcinoma?
March 25, 2021
Ten Things to Know When You are Diagnosed with Skin Cancer
March 19, 2021
Increased risk of skin cancer linked to long-term use of hydrochlorothiazide or indapamide diuretics
March 19, 2021
What is nonmelanoma skin cancer?
March 18, 2021
Understanding different types of skin tumors and how they are treated
March 16, 2021
Symptoms of Ear Cancer and When to See a Doctor
March 11, 2021
How sun-protective behaviors vary among different populations
March 8, 2021
Sanford Health will hold free skin cancer screenings in Bemidji, Minnesota on March 18th, available by appointment
March 1, 2021
A patient with basal cell carcinoma discusses his cancer journey and what to do when hedgehog therapy fails
February 25, 2021
Learn to spot early warning signs of skin cancer
February 24, 2021
A personalized gene expression profile test for use in squamous cell carcinoma may be useful for assessing individual risk of skin cancer
February 22, 2021
MediWound announces clinical trial evaluating new drug candidate MWPC005, a topically applied biological product, to treat non-melanoma skin cancers
February 20, 2021
Mary Bird Perkins Cancer Center in Louisiana to provide free skin cancer screenings in March
February 18, 2021
Artificial Intelligence has the potential to identify skin cancer lesions from smartphone pictures
February 17, 2021
Dermatologist discusses Mohs Micrographic Surgery as a less invasive alternative for skin cancer that is caught early
February 11, 2021
The four most common types of skin cancer and tips to prevent them
February 10, 2021
COVID-19 healthcare delays may lead to your cancer being diagnosed at a later stage
February 9, 2021
Should you worry about skin cancer during the Winter?
February 7, 2021
Learn about the use of photodynamic light therapy for pre-cancerous actinic keratoses
February 6, 2021
New study suggests grape consumption protects against UV skin damage
January 14, 2021
Black patients with Merkel Cell Carcinoma Experience Treatment Delays
January 14, 2021
What Is Skin Cancer on the Scalp?
January 13, 2021
FDA Fast Tracks New Option for Merkel Cell Carcinoma and Cutaneous Squamous Cell Carcinoma
January 9, 2021
Cavrotolimod Plus PD-1 Blockers Showing Efficacy in Advanced Cancers, Including Merkel Cell Carcinoma
December 10, 2020
Diuretic linked to skin cancer
December 9, 2020
Metformin Use May Reduce Risk for Skin Cancer in Patients at Risk for Keratinocyte Carcinomas
December 8, 2020
Artificial Intelligence Being Developed for Skin Cancer Screening
November 30, 2020
Skin cancer six times more likely in surfers and swimmers
November 7, 2020
Nicotinamide pretreatment may protect skin from UVB damage
October 21, 2020
Debunking myths about sun and tanning
October 16, 2020
Post-ESMO Webinar
October 14, 2020
Study suggests no association between use of eczema drugs and skin cancer risk
September 18, 2020
Libtayo (Cemiplimab) shows promising results in advanced basal cell carcinoma
September 15, 2020
Patients with chronic lymphocytic leukemia at higher risk of squamous cell cancer of the skin if they have a history of the disease
September 15, 2020
Preliminary data suggest diets may reduce risk of basal cell carcinoma
August 20, 2020
NFL head coach Ron Rivera diagnosed with cutaneous squamous cell cancer
June 24, 2020
FDA Approves Pembrolizumab for Cutaneous Squamous Cell Carcinoma
May 6, 2020
Cemiplimab Shows Promise for Patients with Advanced Basal Cell Carcinoma
April 10, 2020
Anti-Cancer Agents as Frontline Treatment of MPNs Lead to Higher Probability of Non-Melanoma Skin Cancers
© 2025 SkinCancerCare, Terranova Medica, LLC, and Integrita Foundation, LLC. All rights reserved.